ASLAN Pharmaceuticals ASLN Stock
ASLAN Pharmaceuticals Price Chart
ASLAN Pharmaceuticals ASLN Financial and Trading Overview
| ASLAN Pharmaceuticals stock price | 0.5 USD |
| Previous Close | 3.87 USD |
| Open | 3.83 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 2900 |
| Day's Range | 3.8 - 3.99 USD |
| 52 Week Range | 1.71 - 4.95 USD |
| Volume | 50.94K USD |
| Avg. Volume | 52.08K USD |
| Market Cap | 65.23M USD |
| Beta (5Y Monthly) | 1.83169 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.67 USD |
ASLN Valuation Measures
| Enterprise Value | 37.83M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.6556016 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.982009 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.7 |
Trading Information
ASLAN Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.83169 |
| 52-Week Change | 106.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.95 USD |
| 52 Week Low | 1.71 USD |
| 50-Day Moving Average | 3.93 USD |
| 200-Day Moving Average | 3.22 USD |
ASLN Share Statistics
| Avg. Volume (3 month) | 52.08K USD |
| Avg. Daily Volume (10-Days) | 48.45K USD |
| Shares Outstanding | 16.35M |
| Float | 9.32M |
| Short Ratio | 0.61 |
| % Held by Insiders | 0.074% |
| % Held by Institutions | 25.21% |
| Shares Short | 42.45K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.71% |
| Return on Equity (ttm) | -209.43% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -54072000 USD |
| Net Income Avi to Common (ttm) | -57557928 USD |
| Diluted EPS (ttm) | -3.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 57.5M USD |
| Total Cash Per Share (mrq) | 3.88 USD |
| Total Debt (mrq) | 37.94M USD |
| Total Debt/Equity (mrq) | 383.57 USD |
| Current Ratio (mrq) | 2.586 |
| Book Value Per Share (mrq) | 0.667 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of ASLAN Pharmaceuticals
| Country | United States |
| State | N/A |
| City | Singapore |
| Address | 3 Temasek Avenue |
| ZIP | 039190 |
| Phone | 65 6817 9598 |
| Website | https://aslanpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 34 |
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal antibody that targets the IL-13 receptor a1 subunit which is being developed for the treatment of atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune diseases. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.
Q&A For ASLAN Pharmaceuticals Stock
What is a current ASLN stock price?
ASLAN Pharmaceuticals ASLN stock price today per share is 0.5 USD.
How to purchase ASLAN Pharmaceuticals stock?
You can buy ASLN shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ASLAN Pharmaceuticals?
The stock symbol or ticker of ASLAN Pharmaceuticals is ASLN.
Which industry does the ASLAN Pharmaceuticals company belong to?
The ASLAN Pharmaceuticals industry is Biotechnology.
How many shares does ASLAN Pharmaceuticals have in circulation?
The max supply of ASLAN Pharmaceuticals shares is 22.63M.
What is ASLAN Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
ASLAN Pharmaceuticals PE Ratio is now.
What was ASLAN Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
ASLAN Pharmaceuticals EPS is -3 USD over the trailing 12 months.
Which sector does the ASLAN Pharmaceuticals company belong to?
The ASLAN Pharmaceuticals sector is Healthcare.
ASLAN Pharmaceuticals ASLN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}